Tumor Specific Recruitment and Reprogramming of Mesenchymal Stem Cells in Tumorigenesis

Stem Cells

Volumn 34, Issue 4, 2016, Pages 1011-1026

  Berger, Liron ^a   Shamai, Yeela ^a   Skorecki, Karl L ^a   Tzukerman, Maty ^a  

^a TECHNION ISRAEL INSTITUTE OF TECHNOLOGY   (Israel)

Author keywords

Animal models of cancer; Gastrointestinal cancers; Tumor microenvironment; Tumor specific recruitment of mesenchymal stem cell; Tumor derived mesenchymal stem cell; Tumor stromal cell interactions

Indexed keywords

CYTOKINE; SCATTER FACTOR; SCATTER FACTOR RECEPTOR; CONDITIONED MEDIUM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER CELL; CANCER CELL LINE; CANCER TISSUE; CARCINOGENESIS; CELL GROWTH; CELL SPECIFICITY; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; LUNG CARCINOMA; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEAR REPROGRAMMING; PROTEIN SECRETION; SIGNAL TRANSDUCTION; STOMACH CARCINOMA; STOMACH TUMOR; TROPISM; TUMOR GROWTH; TUMOR MICROENVIRONMENT; TUMOR VOLUME; TUMOR XENOGRAFT; ADIPOCYTE; BIOSYNTHESIS; CANCER STEM CELL; CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CHONDROCYTE; CONDITIONED MEDIUM; EPITHELIUM CELL; GENE EXPRESSION REGULATION; GENETICS; LUNG TUMOR; MESENCHYMAL STROMA CELL; METABOLISM; OSTEOBLAST; PATHOLOGY; TUMOR CELL LINE;

ADIPOCYTES; CARCINOGENESIS; CARCINOMA; CELL CYCLE; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; CHONDROCYTES; CULTURE MEDIA, CONDITIONED; EPITHELIAL CELLS; GENE EXPRESSION REGULATION, NEOPLASTIC; HEPATOCYTE GROWTH FACTOR; HUMANS; LUNG NEOPLASMS; MESENCHYMAL STROMAL CELLS; NEOPLASTIC STEM CELLS; OSTEOBLASTS; PROTO-ONCOGENE PROTEINS C-MET; SIGNAL TRANSDUCTION; STOMACH NEOPLASMS;

EID: 84964331124     PISSN: 10665099     EISSN: 15494918     Source Type: Journal    
DOI: 10.1002/stem.2269     Document Type: Article

References (52)

1. Junttila MR, de Sauvage FJ,. Influence of tumour micro-environment heterogeneity on therapeutic response. Nature 2013; 501: 346-354.
2. Bergfeld SA, DeClerck YA,. Bone marrow-derived mesenchymal stem cells and the tumor microenvironment. Cancer Metast Rev 2010; 29: 249-261.
3. Nishimura K, Semba S, Aoyagi K, et al., Mesenchymal stem cells provide an advantageous tumor microenvironment for the restoration of cancer stem cells. Pathobiology 2012; 79: 290-306.
4. Folkman J,. A novel anti-vascular therapy for cancer. Cancer Biol Ther 2004; 3: 338-339.
5. de Visser KE, Korets LV, Coussens LM,. De novo carcinogenesis promoted by chronic inflammation is B lymphocyte dependent. Cancer Cell 2005; 7: 411-423.
6. Kuperwasser C, Chavarria T, Wu M, et al., Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci USA 2004; 101: 4966-4971.
7. Orimo A, Weinberg RA,. Stromal fibroblasts in cancer: A novel tumor-promoting cell type. Cell Cycle 2006; 5: 1597-1601.
8. Kalluri R, Zeisberg M,. Fibroblasts in cancer. Nat Rev Cancer 2006; 6: 392-401.
9. Madar S, Goldstein I, Rotter V,. " Cancer associated fibroblasts"-More than meets the eye. Trends Mol Med 2013; 19: 447-453.
10. Sung SY, Hsieh CL, Wu D, et al., Tumor microenvironment promotes cancer progression, metastasis, and therapeutic resistance. Curr Probl Cancer 2007; 31: 36-100.
11. Kansy BA, Dissmann PA, Hemeda H, et al., The bidirectional tumor-mesenchymal stromal cell interaction promotes the progression of head and neck cancer. Stem Cell Res Ther 2014; 5: 95.
12. Horwitz EM, Le Blanc K, Dominici M, et al., Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement. Cytotherapy 2005; 7: 393-395.
13. Dominici M, Le Blanc K, Mueller I, et al., Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement. Cytotherapy 2006; 8: 315-317.
14. Roson-Burgo B, Sanchez-Guijo F, Del Canizo C, et al., Transcriptomic portrait of human Mesenchymal Stromal/Stem cells isolated from bone marrow and placenta. BMC Genom 2014; 15: 910.
15. Quante M, Tu SP, Tomita H, et al., Bone marrow-derived myofibroblasts contribute to the mesenchymal stem cell niche and promote tumor growth. Cancer Cell 2011; 19: 257-272.
16. Karnoub AE, Dash AB, Vo AP, et al., Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 2007; 449: 557-563.
17. Hanahan D, Coussens LM,. Accessories to the crime: Functions of cells recruited to the tumor microenvironment. Cancer Cell 2012; 21: 309-322.
18. Sasportas LS, Kasmieh R, Wakimoto H, et al., Assessment of therapeutic efficacy and fate of engineered human mesenchymal stem cells for cancer therapy. Proc Natl Acad Sci USA 2009; 106: 4822-4827.
19. Shah K,. Mesenchymal stem cells engineered for cancer therapy. Adv Drug Deliv Rev 2012; 64: 739-748.
20. D'Souza-Schorey C, Clancy JW,. Tumor-derived microvesicles: Shedding light on novel microenvironment modulators and prospective cancer biomarkers. Genes Dev 2012; 26: 1287-1299.
21. Wysoczynski M, Ratajczak MZ,. Lung cancer secreted microvesicles: Underappreciated modulators of microenvironment in expanding tumors. Int J Cancer 2009; 125: 1595-1603.
22. Cocucci E, Racchetti G, Meldolesi J,. Shedding microvesicles: Artefacts no more. Trends cell Biol 2009; 19: 43-51.
23. Pap E,. The role of microvesicles in malignancies. Adv Exp Med Biol 2011; 714: 183-199.
24. Imperlini E, Colavita I, Caterino M, et al., The secretome signature of colon cancer cell lines. J Cell Biochem 2013; 114: 2577-2587.
25. Zeng X, Yang P, Chen B, et al., Quantitative secretome analysis reveals the interactions between epithelia and tumor cells by in vitro modulating colon cancer microenvironment. J Proteom 2013; 89: 51-70.
26. Castellana D, Zobairi F, Martinez MC, et al., Membrane microvesicles as actors in the establishment of a favorable prostatic tumoral niche: A role for activated fibroblasts and CX3CL1-CX3CR1 axis. Cancer Res 2009; 69: 785-793.
27. Muralidharan-Chari V, Clancy JW, Sedgwick A, et al., Microvesicles: Mediators of extracellular communication during cancer progression. J Cell Sci 2010; 123: 1603-1611.
28. Camacho L, Guerrero P, Marchetti D,. MicroRNA and protein profiling of brain metastasis competent cell-derived exosomes. PloS One 2013; 8: e73790.
29. Properzi F, Logozzi M, Fais S,. Exosomes: The future of biomarkers in medicine. Biomark Med 2013; 7: 769-778.
30. Tzukerman M, Rosenberg T, Ravel Y, et al., An experimental platform for studying growth and invasiveness of tumor cells within teratomas derived from human embryonic stem cells. Proc Natl Acad Sci USA 2003; 100: 13507-13512.
31. Tzukerman M, Rosenberg T, Reiter I, et al., The influence of a human embryonic stem cell-derived microenvironment on targeting of human solid tumor xenografts. Cancer Res 2006; 66: 3792-3801.
32. Katz E, Skorecki K, Tzukerman M,. Niche-dependent tumorigenic capacity of malignant ovarian ascites-derived cancer cell subpopulations. Clin Cancer Res 2009; 15: 70-80.
33. Abelson S, Shamai Y, Berger L, et al., Intratumoral heterogeneity in the self-renewal and tumorigenic differentiation of ovarian cancer. Stem Cells 2012; 30: 415-424.
34. Abelson S, Shamai Y, Berger L, et al., Niche-dependent gene expression profile of intratumoral heterogeneous ovarian cancer stem cell populations. PloS One 2013; 8: e83651.
35. Jamil S, Cedervall J, Hultman I, et al., Neuroblastoma cells injected into experimental mature teratoma reveal a tropism for embryonic loose mesenchyme. Int J Oncol 2013; 43: 831-838.
36. Jamil S, Hultman I, Cedervall J, et al., Tropism of the in situ growth from biopsies of childhood neuroectodermal tumors following transplantation into experimental teratoma. Int J Cancer 2014; 134: 1630-1637.
37. Thomas GM, Panicot-Dubois L, Lacroix R, et al., Cancer cell-derived microparticles bearing P-selectin glycoprotein ligand 1 accelerate thrombus formation in vivo. J Exp Med 2009; 206: 1913-1927.
38. Gherardi E, Birchmeier W, Birchmeier C, et al., Targeting MET in cancer: Rationale and progress. Nat Rev Cancer 2012; 12: 89-103.
39. Boccaccio C, Comoglio PM,. Invasive growth: A MET-driven genetic programme for cancer and stem cells. Nat Rev Cancer 2006; 6: 637-645.
40. Bottaro DP, Rubin JS, Faletto DL, et al., Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product. Science 1991; 251: 802-804.
41. Christensen JG, Schreck R, Burrows J, et al., A selective small molecule inhibitor of c-Met kinase inhibits c-Met-dependent phenotypes in vitro and exhibits cytoreductive antitumor activity in vivo. Cancer Res 2003; 63: 7345-7355.
42. Espagnolle N, Guilloton F, Deschaseaux F, et al., CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J Cell Mol Med 2014; 18: 104-114.
43. Schmid R, Baum P, Ittrich C, et al., Comparison of normalization methods for Illumina BeadChip HumanHT-12 v3. BMC Genom 2010; 11: 349.
44. Bruno S, Collino F, Iavello A, et al., Effects of mesenchymal stromal cell-derived extracellular vesicles on tumor growth. Front Immunol 2014; 5: 382.
45. Brill A, Elinav H, Varon D,. Differential role of platelet granular mediators in angiogenesis. Cardiovasc Res 2004; 63: 226-235.
46. Sun Z, Wang S, Zhao RC,. The roles of mesenchymal stem cells in tumor inflammatory microenvironment. J Hematol Oncol 2014; 7: 14.
47. Hoag H,. Drug development: A chance of survival. Nature 2014; 515: S118-S120.
48. Li W, Zhou Y, Yang J, et al., Gastric cancer-derived mesenchymal stem cells prompt gastric cancer progression through secretion of interleukin-8. J Expl Clin Cancer Res 2015; 34: 52.
49. Chu H, Luo H, Wang H, et al., Silencing BMP-2 expression inhibits A549 and H460 cell proliferation and migration. Diag Pathol 2014; 9: 123.
50. Bruzzese F, Hagglof C, Leone A, et al., Local and systemic protumorigenic effects of cancer-associated fibroblast-derived GDF15. Cancer Res 2014; 74: 3408-3417.
51. Lefterova MI, Haakonsson AK, Lazar MA, et al., PPARgamma and the global map of adipogenesis and beyond. Trends Endocrinol Metabol 2014; 25: 293-302.
52. Eyre R, Harvey I, Stemke-Hale K, et al., Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population. Tumour Biol 2014; 35: 9879-9892.